Clinician’s perspective for personalized medicine and genetic testing as the future of cancer diagnosis

Journal Title: Stanley Medical Journal - Year 2016, Vol 3, Issue 3

Abstract

Molecular diagnostics offer a promise of reducing the length, cost and uncertainty of new molecular entities and potentially unlocking targets for precision medicine through: patient susceptibility to disease; patient respond to treatment or any adverse events; disease progression; proof-of-concept targets correct pathway and success of treatment. Molecular diagnostic tests have emerged as one of the successful means for providing critical insights about disease diagnostics and treatment. The personalized medicine is becoming a reality not only for precise diagnosis but also providing targets towards development of successful therapy for cancer patients. To ensure that new therapies are delivered to the right patients through accurate diagnosis, it is essential to adopt the recommendations for molecular diagnostics as well as therapeutics. Molecular biomarkers can not only serve as predictive for clinical management of cancer but also provide a hope for targeted therapy. With the cost of genomic technologies coming down and results are more clinically relevant, it is possible to predict precise genetic variations that occur in cancer patients. However, awareness is required to reduce cost phenomenally altering cancer management in a better way. To make it reality consortium of oncologists is recommended for development of Indian patient specific biomarker study

Authors and Affiliations

Anita Ramesh, Subbu Apparsundaram, Karthikeyan Rajamani, Ramesh K Goyal

Keywords

Related Articles

Prevalence of Sub-clinical Hypothyroidismin Type 2 Diabetes Mellitus

Background: Diabetes Mellitus and thyroid disorders are two major endocrine diseases that mutually influence each other. The association between thyroid dysfunction and Type 1 DM has long been recognized, although the pr...

CLINICOPATHOLOGICAL CORRELATION OF ESTROGEN RECEPTOR ALPHA GENE POLYMORPHISM AND ESTROGEN RECEPTOR IN BREAST CANCER

Seldom has a disease evoked more interest and dreadful fear in the common man like it has for cancer. Breast cancer, amongst all cancers, continues to evoke such responses and even more research, especially since the tr...

ASSESSMENT OF THE AWARENESS LEVELS AMONG MOTHERS REGARDING INFANT FEEDING PRACTICES IN THE RURAL FIELD PRACTICE AREA OF SIDDHARTHA MEDICAL COLLEGE, VIJAYAWADA

Context: In India about 1.9 million children die every year before they see their first birthday. During the weaning period, one out of four surviving children receives neither the quality nor the quantity of food needed...

Evaluation of ct guided neurolysis in the management of pain in infiltrative pelvic m alignancies

Aim: To evaluate the efficacy of CT guided neurolytic procedures in the management of pelvic malignancy pain including CT guided chemical lumbar sympathectomy for lower limb pain and CT guided presacral and precoccyge...

Malignant parotid tumor with sialadenitis - a diagnostic dilemma

Malignant parotid tumor associated with chronic sialadenitis is rare entity. These tumors mostly arise from epithelial component of chronic sialadenitis. Chronic sialadenitis of parotid with malignant epithelial tumor ev...

Download PDF file
  • EP ID EP217342
  • DOI -
  • Views 81
  • Downloads 0

How To Cite

Anita Ramesh, Subbu Apparsundaram, Karthikeyan Rajamani, Ramesh K Goyal (2016). Clinician’s perspective for personalized medicine and genetic testing as the future of cancer diagnosis. Stanley Medical Journal, 3(3), 119-127. https://europub.co.uk/articles/-A-217342